Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 548bb (miR-548bb) is a member of the miR-548 family, a group of primate-specific microRNAs that function as non-coding RNAs regulating gene expression post-transcriptionally, typically by binding to complementary sequences in the 3′ untranslated region (UTR) of target messenger RNAs (mRNAs), resulting in their degradation or translational repression. There is limited or no direct experimental characterization available for miR-548bb individually, and most data refers to broader activities of the miR-548 family or cluster, such as regulating genes involved in inflammation (including HMGB1) and possibly affecting the pathogenesis of preterm birth. miRNAs as a class are not considered traditional drug targets like proteins (enzymes, receptors, or transporters), and there are currently no drugs or approved therapies known to directly target miR-548bb. The repeated mention of MI0029321 suggests database referencing rather than distinct biological function. Key clarification: - There is no evidence that microRNA 548bb (miR-548bb) is a canonical or direct therapeutic target (such as a receptor, protein, enzyme, or transporter). It is a regulatory RNA, and the available literature refers primarily to the broader miR-548 family or cluster, not to the individual miR-548bb. - The entry is considered incorrect as a therapeutic "target" in the classical sense and lacks supporting data that would characterize it as such. Additionally, direct, specific functional or disease associations for miR-548bb (as opposed to the cluster/family) appear to be missing from current literature.
Post-transcriptional repression of mRNA (through binding to target mRNA 3' UTR, promoting degradation or translation inhibition)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 548bb (miR-548bb).